Global Latent Tuberculosis Infection Screening Test Market Growth (Status and Outlook) 2026-2032
The global Latent Tuberculosis Infection Screening Test market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
United States market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Latent Tuberculosis Infection Screening Test players cover Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Latent Tuberculosis Infection Screening Test Industry Forecast” looks at past sales and reviews total world Latent Tuberculosis Infection Screening Test sales in 2025, providing a comprehensive analysis by region and market sector of projected Latent Tuberculosis Infection Screening Test sales for 2026 through 2032. With Latent Tuberculosis Infection Screening Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latent Tuberculosis Infection Screening Test industry.
This Insight Report provides a comprehensive analysis of the global Latent Tuberculosis Infection Screening Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Latent Tuberculosis Infection Screening Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latent Tuberculosis Infection Screening Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latent Tuberculosis Infection Screening Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latent Tuberculosis Infection Screening Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Latent Tuberculosis Infection Screening Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
United States market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Latent Tuberculosis Infection Screening Test is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Latent Tuberculosis Infection Screening Test players cover Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Latent Tuberculosis Infection Screening Test Industry Forecast” looks at past sales and reviews total world Latent Tuberculosis Infection Screening Test sales in 2025, providing a comprehensive analysis by region and market sector of projected Latent Tuberculosis Infection Screening Test sales for 2026 through 2032. With Latent Tuberculosis Infection Screening Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latent Tuberculosis Infection Screening Test industry.
This Insight Report provides a comprehensive analysis of the global Latent Tuberculosis Infection Screening Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Latent Tuberculosis Infection Screening Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latent Tuberculosis Infection Screening Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latent Tuberculosis Infection Screening Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latent Tuberculosis Infection Screening Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Latent Tuberculosis Infection Screening Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
- Hospital
- Diagnostic Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qiagen
- Oxford Immunotec
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Sanofi
- Par Sterile
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent Tuberculosis Infection Screening Test Market Size (2021-2032)
2.1.2 Latent Tuberculosis Infection Screening Test Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Latent Tuberculosis Infection Screening Test by Country/Region (2021, 2025 & 2032)
2.2 Latent Tuberculosis Infection Screening Test Segment by Type
2.2.1 Tuberculin Skin Test (TST)
2.2.2 Interferon Gamma Released Assay (IGRA)
2.2.3 Latent Tuberculosis Infection Screening Test Market Size by Type
2.2.3.1 Latent Tuberculosis Infection Screening Test Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
2.3 Latent Tuberculosis Infection Screening Test Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Laboratories
2.3.3 Others
2.3.4 Latent Tuberculosis Infection Screening Test Market Size by Application
2.3.4.1 Latent Tuberculosis Infection Screening Test Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
3 LATENT TUBERCULOSIS INFECTION SCREENING TEST MARKET SIZE BY PLAYER
3.1 Latent Tuberculosis Infection Screening Test Market Size Market Share by Player
3.1.1 Global Latent Tuberculosis Infection Screening Test Revenue by Player (2021-2026)
3.1.2 Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player (2021-2026)
3.2 Global Latent Tuberculosis Infection Screening Test Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION SCREENING TEST BY REGION
4.1 Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026)
4.2 Global Latent Tuberculosis Infection Screening Test Annual Revenue by Country/Region (2021-2026)
4.3 Americas Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.4 APAC Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.5 Europe Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.6 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026)
5.2 Americas Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
5.3 Americas Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026)
6.2 APAC Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
6.3 APAC Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026)
7.2 Europe Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
7.3 Europe Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent Tuberculosis Infection Screening Test by Region (2021-2026)
8.2 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
8.3 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TUBERCULOSIS INFECTION SCREENING TEST MARKET FORECAST
10.1 Global Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.1.1 Global Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.1.2 Americas Latent Tuberculosis Infection Screening Test Forecast
10.1.3 APAC Latent Tuberculosis Infection Screening Test Forecast
10.1.4 Europe Latent Tuberculosis Infection Screening Test Forecast
10.1.5 Middle East & Africa Latent Tuberculosis Infection Screening Test Forecast
10.2 Americas Latent Tuberculosis Infection Screening Test Forecast by Country (2027-2032)
10.2.1 United States Market Latent Tuberculosis Infection Screening Test Forecast
10.2.2 Canada Market Latent Tuberculosis Infection Screening Test Forecast
10.2.3 Mexico Market Latent Tuberculosis Infection Screening Test Forecast
10.2.4 Brazil Market Latent Tuberculosis Infection Screening Test Forecast
10.3 APAC Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.3.1 China Latent Tuberculosis Infection Screening Test Market Forecast
10.3.2 Japan Market Latent Tuberculosis Infection Screening Test Forecast
10.3.3 Korea Market Latent Tuberculosis Infection Screening Test Forecast
10.3.4 Southeast Asia Market Latent Tuberculosis Infection Screening Test Forecast
10.3.5 India Market Latent Tuberculosis Infection Screening Test Forecast
10.3.6 Australia Market Latent Tuberculosis Infection Screening Test Forecast
10.4 Europe Latent Tuberculosis Infection Screening Test Forecast by Country (2027-2032)
10.4.1 Germany Market Latent Tuberculosis Infection Screening Test Forecast
10.4.2 France Market Latent Tuberculosis Infection Screening Test Forecast
10.4.3 UK Market Latent Tuberculosis Infection Screening Test Forecast
10.4.4 Italy Market Latent Tuberculosis Infection Screening Test Forecast
10.4.5 Russia Market Latent Tuberculosis Infection Screening Test Forecast
10.5 Middle East & Africa Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.5.1 Egypt Market Latent Tuberculosis Infection Screening Test Forecast
10.5.2 South Africa Market Latent Tuberculosis Infection Screening Test Forecast
10.5.3 Israel Market Latent Tuberculosis Infection Screening Test Forecast
10.5.4 Turkey Market Latent Tuberculosis Infection Screening Test Forecast
10.6 Global Latent Tuberculosis Infection Screening Test Forecast by Type (2027-2032)
10.7 Global Latent Tuberculosis Infection Screening Test Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Latent Tuberculosis Infection Screening Test Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qiagen
11.1.1 Qiagen Company Information
11.1.2 Qiagen Latent Tuberculosis Infection Screening Test Product Offered
11.1.3 Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Qiagen Main Business Overview
11.1.5 Qiagen Latest Developments
11.2 Oxford Immunotec
11.2.1 Oxford Immunotec Company Information
11.2.2 Oxford Immunotec Latent Tuberculosis Infection Screening Test Product Offered
11.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Oxford Immunotec Main Business Overview
11.2.5 Oxford Immunotec Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product Offered
11.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product Offered
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Latent Tuberculosis Infection Screening Test Product Offered
11.5.3 Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Par Sterile
11.6.1 Par Sterile Company Information
11.6.2 Par Sterile Latent Tuberculosis Infection Screening Test Product Offered
11.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Par Sterile Main Business Overview
11.6.5 Par Sterile Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent Tuberculosis Infection Screening Test Market Size (2021-2032)
2.1.2 Latent Tuberculosis Infection Screening Test Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Latent Tuberculosis Infection Screening Test by Country/Region (2021, 2025 & 2032)
2.2 Latent Tuberculosis Infection Screening Test Segment by Type
2.2.1 Tuberculin Skin Test (TST)
2.2.2 Interferon Gamma Released Assay (IGRA)
2.2.3 Latent Tuberculosis Infection Screening Test Market Size by Type
2.2.3.1 Latent Tuberculosis Infection Screening Test Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
2.3 Latent Tuberculosis Infection Screening Test Segment by Application
2.3.1 Hospital
2.3.2 Diagnostic Laboratories
2.3.3 Others
2.3.4 Latent Tuberculosis Infection Screening Test Market Size by Application
2.3.4.1 Latent Tuberculosis Infection Screening Test Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
3 LATENT TUBERCULOSIS INFECTION SCREENING TEST MARKET SIZE BY PLAYER
3.1 Latent Tuberculosis Infection Screening Test Market Size Market Share by Player
3.1.1 Global Latent Tuberculosis Infection Screening Test Revenue by Player (2021-2026)
3.1.2 Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player (2021-2026)
3.2 Global Latent Tuberculosis Infection Screening Test Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION SCREENING TEST BY REGION
4.1 Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026)
4.2 Global Latent Tuberculosis Infection Screening Test Annual Revenue by Country/Region (2021-2026)
4.3 Americas Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.4 APAC Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.5 Europe Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
4.6 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026)
5.2 Americas Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
5.3 Americas Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026)
6.2 APAC Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
6.3 APAC Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026)
7.2 Europe Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
7.3 Europe Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent Tuberculosis Infection Screening Test by Region (2021-2026)
8.2 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026)
8.3 Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TUBERCULOSIS INFECTION SCREENING TEST MARKET FORECAST
10.1 Global Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.1.1 Global Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.1.2 Americas Latent Tuberculosis Infection Screening Test Forecast
10.1.3 APAC Latent Tuberculosis Infection Screening Test Forecast
10.1.4 Europe Latent Tuberculosis Infection Screening Test Forecast
10.1.5 Middle East & Africa Latent Tuberculosis Infection Screening Test Forecast
10.2 Americas Latent Tuberculosis Infection Screening Test Forecast by Country (2027-2032)
10.2.1 United States Market Latent Tuberculosis Infection Screening Test Forecast
10.2.2 Canada Market Latent Tuberculosis Infection Screening Test Forecast
10.2.3 Mexico Market Latent Tuberculosis Infection Screening Test Forecast
10.2.4 Brazil Market Latent Tuberculosis Infection Screening Test Forecast
10.3 APAC Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.3.1 China Latent Tuberculosis Infection Screening Test Market Forecast
10.3.2 Japan Market Latent Tuberculosis Infection Screening Test Forecast
10.3.3 Korea Market Latent Tuberculosis Infection Screening Test Forecast
10.3.4 Southeast Asia Market Latent Tuberculosis Infection Screening Test Forecast
10.3.5 India Market Latent Tuberculosis Infection Screening Test Forecast
10.3.6 Australia Market Latent Tuberculosis Infection Screening Test Forecast
10.4 Europe Latent Tuberculosis Infection Screening Test Forecast by Country (2027-2032)
10.4.1 Germany Market Latent Tuberculosis Infection Screening Test Forecast
10.4.2 France Market Latent Tuberculosis Infection Screening Test Forecast
10.4.3 UK Market Latent Tuberculosis Infection Screening Test Forecast
10.4.4 Italy Market Latent Tuberculosis Infection Screening Test Forecast
10.4.5 Russia Market Latent Tuberculosis Infection Screening Test Forecast
10.5 Middle East & Africa Latent Tuberculosis Infection Screening Test Forecast by Region (2027-2032)
10.5.1 Egypt Market Latent Tuberculosis Infection Screening Test Forecast
10.5.2 South Africa Market Latent Tuberculosis Infection Screening Test Forecast
10.5.3 Israel Market Latent Tuberculosis Infection Screening Test Forecast
10.5.4 Turkey Market Latent Tuberculosis Infection Screening Test Forecast
10.6 Global Latent Tuberculosis Infection Screening Test Forecast by Type (2027-2032)
10.7 Global Latent Tuberculosis Infection Screening Test Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Latent Tuberculosis Infection Screening Test Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qiagen
11.1.1 Qiagen Company Information
11.1.2 Qiagen Latent Tuberculosis Infection Screening Test Product Offered
11.1.3 Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Qiagen Main Business Overview
11.1.5 Qiagen Latest Developments
11.2 Oxford Immunotec
11.2.1 Oxford Immunotec Company Information
11.2.2 Oxford Immunotec Latent Tuberculosis Infection Screening Test Product Offered
11.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Oxford Immunotec Main Business Overview
11.2.5 Oxford Immunotec Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product Offered
11.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product Offered
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Latent Tuberculosis Infection Screening Test Product Offered
11.5.3 Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Par Sterile
11.6.1 Par Sterile Company Information
11.6.2 Par Sterile Latent Tuberculosis Infection Screening Test Product Offered
11.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Par Sterile Main Business Overview
11.6.5 Par Sterile Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Latent Tuberculosis Infection Screening Test Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Latent Tuberculosis Infection Screening Test Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tuberculin Skin Test (TST)
Table 4. Major Players of Interferon Gamma Released Assay (IGRA)
Table 5. Latent Tuberculosis Infection Screening Test Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Table 8. Latent Tuberculosis Infection Screening Test Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Table 11. Global Latent Tuberculosis Infection Screening Test Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player (2021-2026)
Table 13. Latent Tuberculosis Infection Screening Test Key Players Head office and Products Offered
Table 14. Latent Tuberculosis Infection Screening Test Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Table 19. Global Latent Tuberculosis Infection Screening Test Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Country (2021-2026)
Table 23. Americas Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Table 25. Americas Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Table 27. APAC Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Table 29. APAC Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Country (2021-2026)
Table 33. Europe Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Latent Tuberculosis Infection Screening Test
Table 39. Key Market Challenges & Risks of Latent Tuberculosis Infection Screening Test
Table 40. Key Industry Trends of Latent Tuberculosis Infection Screening Test
Table 41. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Qiagen Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 46. Qiagen Latent Tuberculosis Infection Screening Test Product Offered
Table 47. Qiagen Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Qiagen Main Business
Table 49. Qiagen Latest Developments
Table 50. Oxford Immunotec Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 51. Oxford Immunotec Latent Tuberculosis Infection Screening Test Product Offered
Table 52. Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Oxford Immunotec Main Business
Table 54. Oxford Immunotec Latest Developments
Table 55. Bio-Rad Laboratories Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 56. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product Offered
Table 57. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bio-Rad Laboratories Main Business
Table 59. Bio-Rad Laboratories Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product Offered
Table 62. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Sanofi Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 66. Sanofi Latent Tuberculosis Infection Screening Test Product Offered
Table 67. Sanofi Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Par Sterile Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 71. Par Sterile Latent Tuberculosis Infection Screening Test Product Offered
Table 72. Par Sterile Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Par Sterile Main Business
Table 74. Par Sterile Latest Developments
Table 1. Latent Tuberculosis Infection Screening Test Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Latent Tuberculosis Infection Screening Test Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Tuberculin Skin Test (TST)
Table 4. Major Players of Interferon Gamma Released Assay (IGRA)
Table 5. Latent Tuberculosis Infection Screening Test Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Table 8. Latent Tuberculosis Infection Screening Test Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Table 11. Global Latent Tuberculosis Infection Screening Test Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player (2021-2026)
Table 13. Latent Tuberculosis Infection Screening Test Key Players Head office and Products Offered
Table 14. Latent Tuberculosis Infection Screening Test Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Table 19. Global Latent Tuberculosis Infection Screening Test Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Country (2021-2026)
Table 23. Americas Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Table 25. Americas Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Table 27. APAC Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Table 29. APAC Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Latent Tuberculosis Infection Screening Test Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Country (2021-2026)
Table 33. Europe Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Latent Tuberculosis Infection Screening Test
Table 39. Key Market Challenges & Risks of Latent Tuberculosis Infection Screening Test
Table 40. Key Industry Trends of Latent Tuberculosis Infection Screening Test
Table 41. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Latent Tuberculosis Infection Screening Test Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Qiagen Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 46. Qiagen Latent Tuberculosis Infection Screening Test Product Offered
Table 47. Qiagen Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Qiagen Main Business
Table 49. Qiagen Latest Developments
Table 50. Oxford Immunotec Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 51. Oxford Immunotec Latent Tuberculosis Infection Screening Test Product Offered
Table 52. Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Oxford Immunotec Main Business
Table 54. Oxford Immunotec Latest Developments
Table 55. Bio-Rad Laboratories Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 56. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product Offered
Table 57. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bio-Rad Laboratories Main Business
Table 59. Bio-Rad Laboratories Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product Offered
Table 62. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Sanofi Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 66. Sanofi Latent Tuberculosis Infection Screening Test Product Offered
Table 67. Sanofi Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Sanofi Main Business
Table 69. Sanofi Latest Developments
Table 70. Par Sterile Details, Company Type, Latent Tuberculosis Infection Screening Test Area Served and Its Competitors
Table 71. Par Sterile Latent Tuberculosis Infection Screening Test Product Offered
Table 72. Par Sterile Latent Tuberculosis Infection Screening Test Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Par Sterile Main Business
Table 74. Par Sterile Latest Developments
LIST OF FIGURES
Figure 1. Latent Tuberculosis Infection Screening Test Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent Tuberculosis Infection Screening Test Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Latent Tuberculosis Infection Screening Test Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Latent Tuberculosis Infection Screening Test Sales Market Share by Country/Region (2025)
Figure 8. Latent Tuberculosis Infection Screening Test Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type in 2025
Figure 10. Latent Tuberculosis Infection Screening Test in Hospital
Figure 11. Global Latent Tuberculosis Infection Screening Test Market: Hospital (2021-2026) & ($ millions)
Figure 12. Latent Tuberculosis Infection Screening Test in Diagnostic Laboratories
Figure 13. Global Latent Tuberculosis Infection Screening Test Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Latent Tuberculosis Infection Screening Test in Others
Figure 15. Global Latent Tuberculosis Infection Screening Test Market: Others (2021-2026) & ($ millions)
Figure 16. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application in 2025
Figure 17. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player in 2025
Figure 18. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Figure 19. Americas Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 20. APAC Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 21. Europe Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 23. Americas Latent Tuberculosis Infection Screening Test Value Market Share by Country in 2025
Figure 24. United States Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Region in 2025
Figure 29. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 30. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 31. China Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 35. India Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Country in 2025
Figure 38. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 39. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 40. Germany Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 41. France Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 54. APAC Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 55. Europe Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 57. United States Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 58. Canada Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 59. Mexico Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 60. Brazil Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 61. China Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 62. Japan Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 63. Korea Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 65. India Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 66. Australia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 67. Germany Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 68. France Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 69. UK Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 70. Italy Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 71. Russia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 72. Egypt Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 73. South Africa Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 74. Israel Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 75. Turkey Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 76. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 1. Latent Tuberculosis Infection Screening Test Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent Tuberculosis Infection Screening Test Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Latent Tuberculosis Infection Screening Test Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Latent Tuberculosis Infection Screening Test Sales Market Share by Country/Region (2025)
Figure 8. Latent Tuberculosis Infection Screening Test Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Type in 2025
Figure 10. Latent Tuberculosis Infection Screening Test in Hospital
Figure 11. Global Latent Tuberculosis Infection Screening Test Market: Hospital (2021-2026) & ($ millions)
Figure 12. Latent Tuberculosis Infection Screening Test in Diagnostic Laboratories
Figure 13. Global Latent Tuberculosis Infection Screening Test Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Latent Tuberculosis Infection Screening Test in Others
Figure 15. Global Latent Tuberculosis Infection Screening Test Market: Others (2021-2026) & ($ millions)
Figure 16. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Application in 2025
Figure 17. Global Latent Tuberculosis Infection Screening Test Revenue Market Share by Player in 2025
Figure 18. Global Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Figure 19. Americas Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 20. APAC Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 21. Europe Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size 2021-2026 ($ millions)
Figure 23. Americas Latent Tuberculosis Infection Screening Test Value Market Share by Country in 2025
Figure 24. United States Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Region in 2025
Figure 29. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 30. APAC Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 31. China Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 35. India Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Country in 2025
Figure 38. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 39. Europe Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 40. Germany Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 41. France Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Latent Tuberculosis Infection Screening Test Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 54. APAC Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 55. Europe Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 57. United States Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 58. Canada Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 59. Mexico Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 60. Brazil Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 61. China Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 62. Japan Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 63. Korea Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 65. India Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 66. Australia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 67. Germany Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 68. France Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 69. UK Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 70. Italy Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 71. Russia Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 72. Egypt Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 73. South Africa Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 74. Israel Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 75. Turkey Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
Figure 76. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Latent Tuberculosis Infection Screening Test Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Latent Tuberculosis Infection Screening Test Market Size 2027-2032 ($ millions)
